TruthArchive.ai - Related Video Feed

We need studies where people test their stools to see if long-term vitamin C improves bifidobacteria. To advance microbiome research, protocols need to be done properly. A clinician cannot recommend different vitamin C products from different stores because of variations in supervision. Selling a specific product ensures consistency, avoiding comparisons between different vitamins. Advancing this research is challenging because natural substances like vitamin C, vitamin D, and naturally occurring microbes cannot be patented. Patenting requires fabricating or modifying something to be new and novel. The speaker realized that forces are trying to stop innovations, despite a clinician's role to help patients with informed consent.

Sugar fuels cancer, as it operates as a fermentation system reliant on it. Despite Otto Warburg receiving a Nobel Prize for his findings, the focus shifted back to chemotherapy and radiation, which do not cure cancer. This approach leads to disease management rather than finding a cure. The financial incentive lies in treating chronic conditions rather than curing them, as the profit comes from those who require ongoing treatment rather than from healthy individuals or those who have passed away.

Drug companies won't test natural substances because they can't be patented. FDA requires testing for safety and efficacy, but natural products won't be tested due to lack of patentability. This creates a cycle where natural remedies are deemed unproven by the FDA.

Dr. Alexis Cohen (Jasmine Cohen) and the host discuss a wide-ranging view of health, science, and society, centered on mitochondria, light biology, and decentralized approaches to knowledge and healing. - On science, health, and authority: - Cohen argues that “we really haven’t been doing science for about seventy years now” and that modern science has become scientism, with people looking to scientists and doctors as authority figures over personal health, even though no one can fully know another’s lived body experience. - She emphasizes that aging is a reflection of mitochondrial heteroplasmy and that there are ways to slow or speed that burden, but contemporary living habits harm mitochondrial health. She asserts there are incentives to promote lifestyle advice that is not monetizable (outdoor activity, barefoot grounding, seasonal eating, movement), which she says slows research and access to information. - The conversation asserts a need to reclaim personal authority over health and to recognize life as magical and miraculous. - Personal entry into Bitcoin and crypto curiosity: - Cohen notes she and her partner became interested in Bitcoin in 2018, with a continued engagement including taking a cryptography course to understand the underlying proofs rather than accepting information at face value. - Background and work: - The host introduces Cohen as a Princeton-trained molecular biologist, a PhD focusing on metabolism, gut health, and circadian biology, who shifted from academic research to helping people rebuild health through nutrition, movement, mitochondrial function, and light exposure. Cohen shares that her own childhood illnesses, weight issues, and colitis prompted a pivot from academia to health coaching, emphasizing ownership of wellbeing through science and practical lifestyle strategies. - Cohen highlights that she values rigorous science but seeks practical lifestyle strategies to empower clients to understand their biology and take ownership of their health. - Dance, embodiment, and biology: - Cohen describes taking up social dancing (salsa, bachata, merengue, fox trot, hustle) and training intensely. She explains dancing challenges the brain in novel ways, requires being guided by a partner, and expands neural connections. - The host shares similar experiences with dance, noting body memory across decades and the importance of movement, rhythm, and social connection for health. - Mitochondria, heteroplasmy, and light: - Cohen explains mitochondria as the battery of the cell, with their own circular DNA and multiple roles in ATP production, biosynthesis, and epigenetic regulation. Heteroplasmy, the mutation burden in mitochondrial DNA, reflects dysfunction that can lead to energy production deficits across tissues. - She notes three key mitochondrial outputs: - ATP production powers cellular processes and metabolism. - Metabolic water production (including deuterium-depleted metabolic water). - Biophotons, photons largely in the UV range, emitted by mitochondria and nucleus during electron transport; older, sicker individuals emit more light due to increased permeability of the system. - Cohen argues aging mirrors mitochondrial heteroplasmy and mutation accumulation, with higher mutation burdens in tissues like immune cells, gut, liver, and brain associated with disease. She also discusses that mitochondria contribute to energy, water, and biophotons, and that modern life elevates heteroplasmy by lifestyle choices. - She argues heteroplasmy can be slowed or sped, and that there are actionable interventions—though the exact list is not exhaustively enumerated in this segment. - Why mitochondrial health isn’t the central target: - Cohen says mitochondrial health research is less profitable because it emphasizes lifestyle and environmental changes rather than drugs, which affects funding and research direction. She describes a system where focusing on broad environmental and lifestyle changes could be financially less lucrative than drug-centered approaches. - She expands on historical dynamics in science, including siloing of scientists and the development of a paywalled academic publishing model, suggesting that the system discourages holistic, integrative approaches that would unify mitochondrial biology with systems biology. - Light, circadian biology, and UVA/UVB: - The discussion shifts to light as a regulator of mitochondria. Cohen divides the sun’s spectrum into ultraviolet (UVB and UVA), visible light, blue light, and near infrared (NIR). She emphasizes that near-infrared light penetrates deeply and stimulates mitochondria, while UVB promotes melanin production via POMC and MSH peptides, affecting energy balance, mood, and metabolism. - UVB light triggers alpha-MSH and beta-endorphin production, the latter contributing to mood and dopamine support, and helps regulate energy expenditure and appetite via POMC-derived pathways; UVB exposure supports melanin synthesis, redox balance, and photoreception across tissues. - UVA light activates Neuropsin receptors on eyes and skin, aiding circadian entrainment and nitric oxide production, which improves vasodilation and nutrient delivery. Neuropsin is present in skin and testes; its stimulation is linked to testosterone and fertility enhancements. UVA also helps anchor local circadian rhythms in tissues. - Cohen discusses the misperception that UV light is universally harmful and argues that melanin is not only protective but can facilitate energy capture from high-energy photons to support energy metabolism in humans. Melanin’s roles extend beyond protection to potential energy transduction, with POMC, MSH, and alpha-MSH linking light exposure to metabolic regulation. - The My Circadian app is recommended as a tool to track sunrise, UVA/UVB rise, and lux (brightness) to optimize exposure. Cohen notes indoor environments rarely exceed 1000 lux, while outdoor brightness can reach 60,000–60,200 lux, significantly impacting serotonin production, mood, and cognition. She emphasizes the importance of bright daytime light for circadian alignment and melatonin suppression at night. - Infrared, LEDs, and indoor lighting: - The conversation covers lighting technologies, noting fluorescent tubes and LEDs minimize near-infrared and maximize blue light, which disrupts circadian rhythms and flicker, stressing the eyes and sympathetic nervous system. Cohen argues that modern lighting deprives people of infrared and UV radiation, both critical for mitochondrial function and circadian health. - She criticizes the push for energy efficiency that reduces thermal and infrared energy, arguing it contributes to systemic health issues. She emphasizes the importance of incandescent and near-infrared-rich lighting for indoor environments and sun exposure to sustain metabolic health. - Grounding, EMF, and environmental exposure: - Grounding (direct contact with the earth) is presented as a way to discharge excess positive charge in tissues, reducing inflammatory burden and supporting mitochondrial function. Cohen shares practical grounding instructions—grounding directly to the earth when possible, wearing natural fibers, and using grounding footwear. - Non-native electromagnetic fields (EMFs) from Wi-Fi, Bluetooth, 5G, and other sources are discussed as contributors to mitochondrial dysfunction and inflammation. Cohen cites Robert Becker’s historical work on non-thermal EMF effects and Havana syndrome as context for potential biological risks. She suggests practical mitigation, including reducing EMF exposure, using Ethernet where possible, and using tinfoil to shield exposure in certain situations. Plant life can absorb EMF, and grounding, sunlight, and strategic use of red and infrared light are recommended to compensate where exposure is high. - The discussion includes practical home strategies, EMF-blocking window panels, EMF-blocking paint, and even temporary shielding (e.g., tinfoil) as a do-it-yourself mitigation approach. - Travel, circadian disruption, and protocols: - Cohen outlines travel challenges: high altitude cosmic radiation exposure (non-AVMF exposure), cabin EMFs, circadian misalignment, and sedentary behavior. She suggests pre- and post-travel strategies such as grounding, sun exposure, hydration, lymphatic support, and blue-light management to ease time-zone transitions. - She promotes an ebook protocol focused on lymphatic support and circadian realignment, available for purchase, with a holiday discount code holydays. Blue-light blocking strategies and red-light strategies are included to facilitate adaptation to new time zones. - Health, mental health, and pediatric considerations: - The hosts discuss mental health concerns, including PTSD, anxiety, and depression, emphasizing circadian regulation, light exposure, sleep hygiene, and reducing screen exposure. Cohen notes the importance of bright daytime light and a dark, cool sleeping environment for sleep quality and mood. She mentions a study showing even small nighttime light exposure can influence daytime metabolic markers, emphasizing the importance of darkness at night. - Birth, medications, and vaccines: - They touch on birth experiences, epidurals, and how early life interventions can influence long-term health and microbiome development. Cohen discusses pain as a portal to healing and critiques reliance on certain pharmaceutical approaches. - On vaccines, Cohen describes observed adverse effects post COVID-19 vaccination, including histamine issues, barrier permeability, and rapid cancer reports linked to vaccine exposure, while underscoring the lack of widespread funding to investigate these relationships. She mentions turbo cancers and batch variation as topics already discussed by researchers like Kevin McKernan and a need for independent inquiry. - Decentralization, science, and Bitcoin again: - Cohen envisions a decentralized health system in which multiple modalities (acupuncture, Chinese medicine, Ayurveda, allopathic medicine) can be tested for proof of work, with outcomes guiding what works best for individuals. She believes decentralization is necessary for genuine innovation, with a future vision of a decentralized, funded light research lab and a retreat model to study circadian biology, mitochondrial function, and nature-based health in diverse environments (North America and equatorial regions). - She sees Bitcoin as a tool that enables financial sovereignty and autonomy, providing an opportunity to fund decentralized science and publish findings on blockchain to protect against censorship. She highlights the potential for Bitcoin to support a lab through deflationary funding and to empower researchers and patients alike. - Closing: - The conversation closes with practical resources: Thinkific-hosted classes, an online book club, and a QuantumU course that reframes science education around decentralized, nature-based principles. Cohen emphasizes accessible contact options (Instagram and email) and a holiday discount for courses and ebooks. The participants express enthusiasm for ongoing collaboration, travel and events, and continued education in Bitcoin, science, and holistic health. Overall, the episode centers on mitochondria as a foundational health driver, the essential role of light and circadian biology in energy, mood, metabolism, and aging, and a call for decentralized, nature-aligned science, with Bitcoin framed as a funding and governance tool to empower individuals and researchers to pursue health innovation beyond centralized institutions.

We should have recommended nationwide vitamin D supplementation to fortify immune systems against severe disease. Vitamin D has been attacked by the pharmaceutical industry for threatening the disease model. They are terrified of it. If you fear vitamins, you're likely on the wrong side.

NIH researchers found significant differences between oral and intravenous (IV) vitamin C intake. IV administration allows for much higher doses than oral intake, as the body has biological controls that limit the absorption of vitamin C when taken orally. For instance, the maximum tolerated oral dose is about 3 grams every 4 hours, while clinical studies indicate that cancer patients can safely tolerate IV doses of 100 grams or more.

Medical schools allegedly don't teach nutrition because they are incentivized to prescribe drugs. The drug lobby ensures this by subsidizing medical school professors. Professors, therefore, promote drugs instead of alternatives like vitamin C. Over a century ago, foundations like Carnegie and Rockefeller allegedly engineered the curriculum through grants and donations.

Drug companies are not interested in natural substances that cannot be patented. The FDA requires substances to be tested for safety and effectiveness before they can be used legally. However, since natural substances cannot be patented, drug companies are unlikely to spend the money to test them. As a result, the FDA will always consider natural substances unproven and condemn them.

The FDA only approves emergency use authorization if there are no other alternatives. Ivermectin's effectiveness could have impacted vaccine approval. Powerful interests oppose Ivermectin due to financial reasons. Drug companies profit greatly from vaccines. Ivermectin is cheap and widely available. Merck's stance on Ivermectin changed after its patent expired. Paid articles may not always provide accurate information.

There are 250,000 drugs in the PDR, but none are designed to cure anything except maybe antibiotics for strep throat. Pharmaceutical companies focus on making money from insurance policies rather than creating cures. Laws do not require them to produce drugs that cure, despite their ability to do so.

It's frustrating that effective treatments used globally aren't considered here. A doctor mentioned that many treatments don't work, and with a high mortality rate, there's little to lose by trying new options. Patients often present with severe breathing difficulties and thick mucus in their lungs, visible on X-rays. Proven treatments exist, like high-dose IV vitamin C, which has shown success in trials, but these are often dismissed. Instead, patients are frequently sedated and placed on ventilators. Despite the historical skepticism surrounding vitamin C, it has potential benefits that are overlooked, leaving many to question the current medical approach.

Vitamin D alone could prevent about 30,000 cancer deaths in a single country in a single year. The study looked in Germany and examined what would happen if they administered wide-scale vitamin D to the 50 and older population. Based on the most recent meta-analyses of vitamin D and cancer, there is about a 13% reduction in cancer mortality, and that is extrapolated to an entire country, resulting in saving about 30,000 lives per year. A recent paper on vitamin D and cancer and its biological effects is highlighted: there are over 900 peer-reviewed recent papers finding that vitamin D, when raised to adequate levels, exhibits anticancer activity against literally basically every single cancer known, through vitamin D receptor signaling as well as tumor microenvironment control and immune modulation. This is described as very, very important as winter months approach, so ensuring adequate vitamin D intake is advised. The speaker notes that some of the most powerful cancer prevention tools are neither profitable nor novel, and vitamin D is very inexpensive, biologically active, and, according to randomized clinical trial evidence, saves lives at scale. The main question posed is why public health agencies are ignoring this.

Anything from nature cannot be patented, so drug companies won't spend millions testing natural substances for FDA approval. The FDA requires efficacy and safety testing, but since natural substances can't be patented, no company will invest in the testing. Therefore, according to the speaker, the FDA will always condemn anything from nature as unproven, regardless of its potential effectiveness.

We should have recommended nationwide vitamin D supplementation to fortify immune systems and protect against severe disease. Vitamin D has been attacked by the pharmaceutical industry for threatening the disease model. They are terrified of it. If you are scared of vitamins, you are probably on the wrong side.

It's frustrating that effective treatments aren't being utilized. A conversation with a doctor revealed that many current treatments aren't working, and there's skepticism about trying new methods. Despite the high mortality rate, some believe it's worth exploring alternatives. Patients often present with severe breathing issues and thick mucus in their lungs, which complicates oxygen transfer. Proven treatments, like high-dose IV vitamin C, have shown success in trials but are dismissed here. Instead, patients are often sedated and placed on ventilators. There's a reluctance to accept these treatments, despite their potential benefits.

There were simple, safe things we knew could boost immune systems and protect against severe disease. We should have recommended vitamin D for everyone. A nationwide vitamin D supplementation campaign would have been very easy. Vitamin D has been attacked for decades by the pharmaceutical industry because it threatens the disease model. We could talk about vitamin D for a long time, but the point is, they're terrified of it. If you're terrified of vitamins, you're probably on the wrong side.

Speaker 0: I have three friends. All three of them had stage four cancer. All three of them don't have cancer right now at all. And they had some serious stuff going on. And what did they take? Yep. Jesus. They took some what you've heard they've taken. Speaker 1: Ivermectin. Fenbendazole. Fenbendazole. Yeah. Speaker 0: That's it. Speaker 1: Yeah. I'm hearing that a lot. Speaker 0: They drank hydrochloride something or other? There's studies on Speaker 1: that now where people have proven that they've Speaker 0: drinking methylene blue and stuff Speaker 1: like that. Yeah. Methylene blue, which was a fabric dye. Speaker 0: Yeah. Yeah. It was a textile dye, and now they find it has profound effects on your mitochondria. Yep. Yeah. Speaker 0: This stuff works, man. There's a lot of stuff that does work, which is very strange Speaker 1: Mhmm. Because, again, it's profit. When you when you hear about things that are demonized and that that turn out to be effective, you always wonder, well, what is going on here? Mhmm. How is how is our medical institutions how have they failed us so that things that do cure you are not promoted because they're not profitable?

The speaker claims there is active suppression of positive vitamin D news and research because it competes with top-selling drugs. The speaker presented data to top vitamin D researchers and faced vicious attacks, with researchers claiming vitamin D doesn't do what the data suggested. The speaker stated they were only presenting assembled data. The speaker was told they were jeopardizing careers of researchers who had spent their lives studying vitamin D, because they never conceived the presented data could be true.

Ivermectin, a Nobel Prize-winning anti-parasitic drug, has been vilified. Merck, who held the patent until 1996, claims it doesn't work for COVID-19. However, Merck has a 50/50 partnership with Moderna on mRNA cancer vaccines. Because Merck will make billions on mRNA cancer vaccines, they have no interest in investigating ivermectin for cancer. There is evidence that high-dose ivermectin is effective in treating many types of cancers.

The forest plot shows COVID medicines, with only expensive ones approved in the US. Cheaper drugs were ignored. Studies manipulated endpoints and faced negative PR. Over 420 trials on hydroxychloroquine and 100 on Ivermectin show significant benefits, but they are dismissed in the US.

Longevity experts and biohackers focus on vitamins and exercise, while only paying lip service to community. They provide exact dosages of supplements, but no guidance on how to socialize. This is because community doesn't generate revenue like vitamin D or other supplements that can be packaged and sold. There is a financial incentive to sell incomplete solutions.

Natural substances cannot be patented, which means drug companies are not interested in testing them for FDA approval. The FDA requires substances to be tested for safety and efficacy before they can be used legally. However, since natural substances cannot be patented, no one is willing to spend the money to conduct these tests. As a result, the FDA will always consider natural substances unproven and condemn them.

Like hydroxychloroquine and ivermectin are no are out of patents. So because they're out of patents, you cannot make any money on these drugs. The most you could sell them for is, $300 Pharmaceutical companies are no longer interested in $300 drugs. They're interested in orphan drugs where they can get name your price for a drug. We're going to put it under an orphan and now we can bill whatever we want. From like $300 to $10,000 a month. Then all these companies started copying and doing biologic at $10,000 a month. But there is a movement that is controlling the research and stopping innovations, that is stopping out of patent drugs, drugs that are basically like hydroxychloroquine and ivermectin. So I think that's the number one thing and the attacks on that.

Reports from China indicate scientists may have found a diabetes cure, which is unwelcome news for the American pharmaceutical industry. Chinese patients receiving experimental stem cell therapy have stopped needing insulin after about eleven weeks. This poses a threat to companies like Eli Lilly, who profit greatly from the insulin market. The rising insulin prices have sparked controversy, especially considering insulin's inventor, Frederick Banting, sold the patent for $1, believing it should be accessible to everyone. A diabetes cure would reduce the demand for insulin, impacting pharmaceutical companies' profits. This reveals a contradiction within the American for-profit healthcare system, where cures are disincentivized if they eliminate the need for repeat customers, challenging the notion that capitalism always promotes innovation.

There is a flood of research on what vitamin D can do for cancer, and it helps in many different ways. Research that shows vitamin D doesn't help is influenced by big pharma. Studies that don't show a favorable outcome use tiny amounts of vitamin D, which is why they don't create the desired effects.